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Summary The Inter-Regional Epidemiological Study of Childhood Cancer included 43 cases of soft tissue
and 30 cases of bone sarcomas, together with their 146 matched controls. Analysis of a wide range of
aetiological factors revealed few risk factors relating to events during the index pregnancy, the earlier medical
experiences of the case child, or parental medical, occupational and smoking history. Associations which did
emerge included: lower birth weight in children with Ewing's tumour, an excess of mothers of children with
soft tissue sarcoma with symptoms of toxaemia in pregnancy; and more children with rhabdomyosarcoma
who received antibiotics soon after birth. There was some evidence that mothers of children with soft tissue
sarcoma may have had reduced fertility with a significant excess of the case mothers having no other
pregnancies. Slight excesses of congenital malformations in the case children and of malignant and benign/
borderline neoplastic disease in the older mothers were consistent with the existence of a degree of genetic
predisposition in the development of the tumours in this series.
Bone and soft tissue sarcomas account for only about 1% of
malignant neoplasms in adults, but form a much higher
proportion, approximately 10%, of childhood cancers.
Certain environmental exposures, e.g. high dose ionising
radiation, vinyl chloride and herbicides, have been suggested
as aetiological agents for soft tissue sarcomas in adults
(Tucker & Fraumeni, 1982) but because of the incidence
peak in early childhood the role of prenatal factors may be
more important in this latter age group. Some evidence
exists for a genetic aetiology in the development of these
tumours in children (Li & Fraumeni, 1969; Birch et al.,
1984). In contrast, the findings of a case control study of
rhabdomyosarcoma in childhood indicated that environ-
mental factors may play an important aetiological role
(Grufferman et al., 1982).
Childhood osteosarcoma and Ewing's tumour have
differing epidemiological characteristics and no environ-
mental causes or familial associations have been separately
identified for Ewing's tumour. Osteosarcoma, however, does
show certain familial aggregations similar to rhabdomyo-
sarcoma, occurs in association with familial retinoblastoma
and can arise in some pre-existing bone defects. The only
well-established environmental cause of osteosarcoma in
adults is exposure to ionising radiation (Miller 1981;
Fraumeni & Boice, 1982).
Amongst the 555 cases and their 1,110 unaffected matched
controls included in the Inter-Regional Epidemiological
Study of Childhood Cancer (IRESCC) there were 43
children with soft tissue sarcoma and 30 children with
malignant bone tumours. The aim of this paper is to
evaluate a wide range of factors in the life of the child and
his or her parents as possible aetiological agents.
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Methods
The Inter-Regional Epidemiological Study of Childhood
Cancer (IRESCC) included newly-diagnosed cases of malig-
nant neoplasms in children under 15 years of age diagnosed
between 1980 and 1983 in three health authority regions;
North Western, West Midlands and Yorkshire. A detailed
description of the methodology for IRESCC is given by
Birch et al. (1985). Interviews were carried out using a
standard questionnaire with the parents of children with
cancer and with the parents of two sets of matched controls.
General practitioner controls (GPC) were chosen from the
case child's current general practitioner listing, and hospital
controls (HC) from children admitted to hospital at the same
time as the case for minor illnesses or accidents. The
interview covered a wide range of factors including
pregnancy events, past medical history of the index child,
medical history of the parents, siblings and other relatives,
together with parental occupations and smoking history.
A special feature of IRESCC was the verification of
medical information obtained at interview. Obstetric records
were routinely abstracted for each case and control preg-
nancy and information on the child's malformations, serious
and chronic illness and long-term medication was sought
from general practitioners. Hospital records were obtained to
confirm serious illnesses including neoplastic disease in the
index child, parents, siblings and other relatives.
Illnesses were coded using the International Classification
of Diseases (WHO, 1978). Social class was coded using
Classification of Occupations (OPCS, 1970) and related to
the father's occupation at the time of the child's birth.
Information for soft tissue sarcomas (STS) and bone
tumours (BT) was analysed separately. Tables for case-
control comparisons were produced using SPSS Version X
(1985) and statistical analyses of cases versus their respective
pooled controls carried out with the aid of EPILOG version
2.0 (1985). x2 and Fisher's exact test were used for cate-
gorical variables and the Mann-Whitney U test to compare
non-normal continuous distributions. Relative risks were
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estimated by the Mantel-Haenzel method and 95% confi-
dence intervals calculated using Cornfield's formula (Breslow
& Day, 1980).
Results
Table I shows the distribution by histological type and sex of
the cases included. The category 'other soft tissue sarcoma'
included single examples of Triton tumour, malignant peri-
pheral nerve sheath tumour, haemangiosarcoma, leiomyo-
sarcoma, liposarcoma, haemangiopericytoma and sarcoma
not otherwise specified. Median age at diagnosis for children
with soft tissue sarcoma was 6 years 9 months and for
children with bone tumours 12 years exactly. There were 6
case children of Asian origin (4BT, 2STS), and the parents
of one of these cases (BT) were related.
Pregnancy events
Case mothers did not differ significantly from their controls
in numbers receiving one or more X-rays, ultrasound scans,
amniocenteses or general anaesthetics (including dental)
during the index pregnancy. No mother reported infection
with chickenpox, measles, mumps, rubella, glandular fever or
infectious hepatitis and numbers of case mothers reporting
influenza, urinary tract infections and 'other' infections did
not differ from their controls. Nor were there any case-
control differences in the frequency of threatened miscarriage
and other complications of pregnancy, other than toxaemia:
an excess of STS case mothers were medically recorded as
having symptoms of toxaemia, i.e. hypertension, oedema,
albuminuria (14C, 6GPC, 7HC; RR=2.71, 95% CI 1.05-
7.06, P=0.04). This excess was not confined to mothers of
children with rhabdomyosarcoma or of other soft tissue
sarcoma nor did the excess of case mothers stated to actually
have 'toxaemia' reach significance (6C, 2GPC, 2HC;
RR=3.32, 95% CI 0.73-16.84, P=0.1).
Analysis of total numbers of drugs and of individual drugs
commonly taken in pregnancy, e.g. antacids, laxatives, anal-
gesics, anti-emetics, diuretics, urinary anti-infectives,
sedatives and tranquillizers did not reveal any case-control
differences. Several of the mothers of older children in the
series had received hormone pregnancy tests (primodos) and
the case excess in STS mothers approached significance (3C,
OGPC, OHC; 95% CI >0.85 P=0.07). Numbers of case
mothers taking any hormone preparation during pregnancy,
including primodos and inadvertent use of the contraceptive
pill early in pregnancy were not significantly in excess. Many
of the children with bone tumours were born in the 1960s
when the contraceptive pill was not as widely used as
subsequently. Hence few BT case or control mothers had
taken the pill at any time prior to the index pregnancy.
Almost half of all STS mothers, whose children were on
average younger at diagnosis and hence born in later
Table I Index cases
Male Female Total
Soft tissue sarcoma:
Rhabdomyosarcoma and
embryonal sarcoma 17 10 27
Fibrosarcoma 4 2 6
Malignant fibrous histiocytoma 2 1 3
Other soft tissue sarcoma 4 3 7
Totals 27 16 43
Bone tumours:
Osteosarcoma 6 6 12
Chondrosarcoma 0 2 2
Ewing's tumour 8 8 16
Totals 14 16 30
decades, had used the pill but again case mothers were not
significantly in excess.
There were no significant case-control differences in
mothers having induced or accelerated labour, in mothers
having one or more drugs in labour or in the total number
of drugs taken in labour. Nor did analysis of labour drugs
grouped as narcotic analgesics, barbiturates or 'other' indi-
cate any carcinogenic effects of any of these preparations.
Case mothers who reported drinking alcohol during the index
pregnancy were not in excess.
Child's past medical experiences
No case-control differences emerged for hospital versus
general practitioner antenatal care and hospital versus home
delivery. However, significantly fewer children with bone
tumours required assisted delivery compared with their
controls (IC, 7GPC, 6HC; RR=0.12, 95% CI 0.00-0.93,
P=0.04). Median length of gestation was 40 weeks for both
STS and BT cases and for their respective pooled controls.
Prolonged gestation of 41 weeks or more did not appear to
be a risk factor for childhood sarcoma.
Children with STS did not differ significantly from their
controls in median birthweight (cases 3,490g, controls
3,310g, reported; cases 3,400g, controls 3,335g, medically
recorded). Overall, children with bone tumours were signifi-
cantly lighter than their controls but this difference was
confined to children with Ewing's tumour (cases 3,015g,
controls 3,400g, reported, P=0.02 Mann-Whitney U test;
cases 3,005g, controls 3,445g, medically recorded, P=0.03).
Median birthweight of children with osteosarcoma and
chondrosarcoma did not differ significantly from that of
their controls (cases 3,330g, controls 3,400g, reported,
P=0.66; cases 3,340g, controls 3,300g, confirmed, P=0.84).
There were no case-control differences for STS or BT
children in condition at birth or in referral to special care
baby units. Numbers of children having exchange trans-
fusion, phototherapy for jaundice, neonatal X-rays or
general anaesthetics were too small for analysis. Breast
feeding did not appear to protect children against developing
soft tissue sarcomas or bone tumours (children diagnosed
with their tumours under 3 months of age were excluded
from this latter analysis).
Congenital abnormalities
For analysis of congenital malformations (ICD9 740-759)
hospital controls were excluded as children with major
abnormalities were not considered eligible. More cases than
controls had congenital abnormalities (Table II) but in
neither diagnostic group was the difference significant. Single
birthmarks were excluded from these analyses.
Previous illnesses
Children with congenital tumours were excluded from
analyses of illnesses occurring under 6 months and those
with tumours diagnosed at age less than 6 months from
analysis of illness over 6 months of age. Cases did not differ
from their controls in total number of illnesses, reported or
confirmed, under 6 months, and 6 months of age and over.
Analysis of reported and confirmed illnesses by the 15 ICD9
chapters revealed no positive associations.
Previous medication and irradiation
Drug ingestion was compared for three periods in the child's
life: in the first month, from 1-5 months and 6 months and
over. All medication given in the first month was coded but
subsequent coding included only that taken on a long-term
basis. Details of neonatal drugs (obstetric notes) and pro-
longed medication over 6 months (GP records) were
available. Drugs were classified as antibiotics, anti-
convulsants, corticosteroids, anti-allergic, bronchodilators,
sedatives, decongestants, cough suppressants and840 A.L. HARTLEY et al.
Table II Index child congenital abnormalities
Case diagnosis
Soft tissue sarcomas:
Cases
Embryonal RMS
Embryonal RMS
Embryonal RMS
Alveolar RMS
Alveolar RMS
Malignant fibrous histiocytoma
Fibrosarcoma meninges
Fibrosarcoma
GP controls:
Embryonal RMS
Leiomyosarcoma
Malignant fibrous histiocytoma
Haemangiopericytoma
Bone tumours:
Cases
Osteosarcoma
Osteosarcoma
Ewings
Ewings
Ewings
Ewings
Ewings
GP controls:
Sex Congential abnormality
M L supernumary nipple
F Skin tag (? rectum)
preauricular pit
F Over-riding 2nd and 3rd toes L footb
4th R toe sticks forwardb
M Tongue-tiea
M Undescended testesa
M Hypospadiasa and club foot
M Absent phalanx 5th L fingera
Bilateral clinodactyly
F Deep sacral dimplea
M Bilateral metatarsus varus'
Bilateral ptosisa
M Bilateral talipes equinovarus
M Slight webbing 2nd and 3rd toes
M L undescended testis. Sinus base of back.
Large purple birthmark on foot.
M
F
M
F
F
M
F
Slight webbing R 2nd and 3rd toes
5th toes crossed over 4th toes
Absent L kidney and ureterb
Low set earsb. Haemangioma L leg, genitals and buttock.
Small naevi occipital region and R upper eyelid".
Absent eyebrows, eyelashes and nails. Persistent lanugo.
Meningomyelocelea
L foot turned in. Brown mark on hand.
Osteosarcoma F Congenital dislocation hip
Osteosarcoma F Congenital dislocation hiF
Osteosarcoma M Tongue-tie
Ewings M Low set ears. Talipes. 16-
aMedically recorded; bNot reported at interview; RMS=Rhabdomyosarcoma.
expectorants, and drugs for gastrointestinal disorders. Out of
48 comparisons made for these drug groups only one
significant difference emerged: children with soft tissue
sarcomas had more medically-recorded reports of having
received antibiotics after birth than their controls (6C,
IGPC, IHC; RR=6.81, 95% CI 1.13-71.18, P=0.03). This
difference was mainly accounted for by children with
rhabdomyosarcoma (RMS) (5C, IGPC, IHC; RR=5.91,
95% CI 0.86-64.88, P=0.08). Examination of the records of
RMS case children who had received antibiotics revealed
that 3 of the 5 had been prescribed penicillin derivatives -
one for aspiration pneumonia, another because of
asphyxiation at birth and another for 'chestiness'. Another
child who received unspecified antibiotics for facial cellulitis
later developed a rhabdomyosarcoma of the maxillary
antrum. Cases and controls did not differ in the total
number of drugs taken at any stage in their lives. No case or
control had received previous therapeutic irradiation.
Immunizations
All children in the BT group were reported as having
received one or more of the following immunizations:
tetanus, diphtheria, whooping cough, poliomyelitis, measles,
rubella and BCG. Three STS case children had received
none of these vaccines compared with one GPC but this case
deficit was not significant (3C, IGPC, OHC; RR=6.37, 95%
CI 0.49-345.32, P=0.2).
Parental factors
Neoplasms: Neoplastic disease in parents is shown in Table
-17 ring chromosome.
III. There was a slight excess of neoplasms in BT mothers
but this did not reach significance (7C, 2GPC, 2HC;
P=0.07).
Previous illnesses: Analysis of reported illnesses by ICD9
chapter, including congenital abnormalities, did not reveal
any significant differences for mothers or fathers in either
diagnostic group. Only one mother (HC) had received
radiotherapy at any time prior to the index child's birth.
Reproductive history: Median age at birth of index child of
STS mothers was 25.7 years and of their pooled controls
25.6 years (P=0.8 Mann-Whitney U test). Mothers of BT
children were older than their controls but this difference
was not significant (cases 25.9 years, controls 25.1 years,
P=0.3). More case mothers than controls were aged 30
years and over at the time of birth of the index child and
this excess was significant for BT mothers (STS 9C, 7GPC,
6HC; RR= 1.49, 95% CI 0.52-4.18 P=0.6; BT 8C, 3GPC,
2HC; RR=4.00, 95% CI 1.01-17.07 P=0.05). This effect is
probably a reflection of the younger age of the BT control
mothers. There were no significant differences between
median ages of STS fathers (cases 27.4 years, controls 28.8
years, P=0.4) and BT fathers (cases 28.6 years, controls 28.2
years, P=0.7).
Although case mothers did not differ significantly from
their controls in total number of pregnancies, mothers of
children with STS had fewer pregnancies with a significant
deficit of miscarriages (6C, 12GPC, 25HC; P=0.01). The
deficit of miscarriages was largely confined to the RMS
group (IC, 6GPC, 15HC; P=0.008). A significant excess ofCASE CONTROL STUDY OF CHILDHOOD SARCOMAS 841
Table III Neoplastic disease in parents
Case diagnosis Relationship Neoplasm Age at diagnosis
Soft tissue sarcomas
Cases:
Embryonal sarcoma Mother Compound naevus R forearm 18 yrs
Fibrosarcoma Mother Fibroadenoma breast 28 yrs
Triton tumour Mother Carcinoma-in-situ cervix 33 yrs
GP controls:
Embryonal RMS Father l Seminoma L testis 47 yrs Mother f Fibroadenoma R breast 29 yrs
Embryonal RMS Mother Fibroadenoma R breast 25 yrs
Fibroadenoma L breast 26 yrs
Leiomyosarcoma Mother Fibromyomata uterus 37 yrs
Hospital controls:
Embryonal RMS Father Large pigmented mole (no malignancy) 9 yrs
Bone tumours
Cases:
Osteosarcoma Father Carcinoma L lung 62 yrs
Osteosarcoma Mother Fibroadenoma R breast 19 yrs
Intradermal naevus spine 40 yrs
Chondrosarcoma Mother Malignant melanoma R thigh 31 yrs
Ewings Mother Hydatidiform mole 24 yrs
Ewings Mother Carcinoma L breast 34 yrs
Ewings Mother Leiomyoma uterus 38 yrs
GP controls:
Osteosarcoma Father Pleomorphic salivary adenoma L 40 yrs
Ewings Mother Fibroadenoma L breast 19 yrs
Hospital controls:
Osteosarcoma Father Hodgkin's disease 31 yrs
Ewings Mother Uterine fibroids 39 yrs
RMS =Rhabdomyosarcoma.
mothers of STS cases had had no pregnancies other than
that of the index child (13C, 5GPC, 3HC; RR=4.22, 95%
CI 1.45-12.57 P=0.005) and this again was accounted for
largely by the RMS group (8C, 2GPC, lHC; RR=7.16,
95% CI 1.48-44.98 P=0.01).
Occupation, social class and smoking history: No case-control
differences were apparent for numbers of mothers working
at any time during the pregnancy with the index child.
Analysis by occupational group was possible only for
workers handling food, drink and tobacco, textile workers,
hairdressers and clerical workers, and no significant
differences emerged for any of these groups. Fathers' occu-
pation for the year before pregnancy and during pregnancy
was analysed for chemical workers, engineering workers,
workers handling food, drink and tobacco, miners and
quarry men, and textile workers. Again no significant
differences emerged.
Analysis of fathers' social class based upon occupation at
the time of the child's birth (Classes I, II, and III versus IV
and V) revealed no significant differences. Similarly analysis
of mothers' and fathers' smoking history before and during
the index pregnancy did not show any case excess.
Discussion
This analysis of the 43 cases of soft tissue sarcoma and 30
cases of bone tumours included in IRESCC has revealed few
risk factors relating to the index pregnancy, the case child's
past medical history or parental medical, occupational or
smoking history. Significant findings relating to pregnancy
history and early experiences of the case child included an
excess of mothers of STS case children with symptoms of
toxaemia and an excess of RMS case children confirmed as
having received antibiotics shortly after birth. This latter
finding is of interest in connection with the report of
Grufferman et al. (1982) that mothers of children with
rhabdomyosarcoma were more likely to have taken anti-
biotics within one year preceding or during the index
pregnancy than their controls. Our study, however, did not
show an excess of mothers confirmed as having taken
antibiotics during the index pregnancy (3C, 4GPC, 3HC).
The possibility exists that the significance of our finding
relates not to the antibiotic use itself, but to underlying
infection for which treatment was given.
The lower birthweight of BT children also concurs with a
report of shorter birth length in young persons with osteo-
sarcoma (Operskalski et al., 1987) although in our study the
lighter birthweight was more apparent in children with
Ewing's tumour. Difference in birthweight could affect later
patterns of growth in these children which in turn might
have some influence on tumour development.
Case children in general had more congenital abnor-
malities than their GP controls, although the differences
were not statistically significant. Developmental anomalies
occurred in five children with Ewing's tumour including one
boy with a meningomyelocele and another with an absent
kidney and ureter. This latter observation supports the
findings of McKeen et al. (1983) of a possible excess of renal
malformations in patients with Ewing's sarcoma. The array
of congenital abnormalities in STS children in IRESCC
shows few similarities with those recently reported from
autopsy findings in a series of children with rhabdomyo-
sarcoma (Ruymann et al., 1988). IRESCC, however, was
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records and overall the numbers of abnormalities recorded
are likely to be an underestimate. No case child or parent in
the series was confirmed as having neurofibromatosis, nor
were any of the common features of this disorder, e.g. cafe
au lait patches, reported.
Although there was an excess of benign and malignant
neoplasms in the parents of children with bone tumours, no
excess was apparent in STS parents in spite of the reported
familial associations with these tumours (Li & Fraumeni,
1969; Birch et al., 1984). Explanations for this could be the
lower median age at diagnosis of STS children and hence the
relatively young ages of the STS parents in this sample of
incident cases, together with the slightly older age of mothers
of BT children compared with their controls. With an
extended period of follow up an excess of cancers in the STS
case mothers might eventually emerge. More detailed
analysis of malignant disease in the families of children in
IRESCC will be presented elsewhere.
The remaining risk factors revealed in this study relate to
aspects of the mothers' reproductive history. Although there
was no evidence of more oyerdue or assisted deliveries in the
case children, the possible excess of older BT mothers
supports a similar finding by Grufferman et al. (1982). Other
factors, such as fewer pregnancies, including miscarriages,
and a large proportion of STS mothers who had no other
pregnancies might point to reduced fertility in STS mothers
which in itself might be linked with their own susceptibility
to breast cancer (Birch et al., 1984). The deficit of other
pregnancies in the case mothers cannot be accounted for by
parental decisions not to have or to delay having further
children as all interviews for IRESCC took place within a
few weeks or months of diagnosis. In contrast with the
findings of Grufferman et al. (1982), socio-economic status
appeared to have little influence on the development of bone
and soft tissue sarcomas in the children of this series. No
case excess was found in relation to fathers' social class or
parental smoking. Environmental factors such as diet or
exposure to chemicals were not addressed by IRESCC bu-t
little evidence from neonatal events and other aspects of the
past medical history of the index child suggested environ-
mental exposures as major putative hazards. In particular we
could not demonstrate any increased risk in relation to
fathers' smoking as shown by Grufferman et al. (1982).
The samples of bone tumours included in IRESCC
included a larger proportion of Ewing's tumour than would
have been expected from incidence statistics (Draper et al.,
1982). This was accounted for by variation in case recruit-
ment of osteosarcoma in the West Midlands region. Our
analyses combine all bone tumours because of small numbers
but the results should be interpreted with caution because of
the differing epidemiological characteristics of Ewing's
tumour and osteosarcoma (Miller, 1981).
Overall, this survey has revealed few indications of risk
factors in the index pregnancy or past medical history of the
child. Because of multiple comparisons some of the signifi-
cant findings may have occurred by chance. Similarly other
risk factors may not have emerged because of the small
nunber of cases analysed. Data on the congenital mal-
formations in the child and parental neoplasms provide
confirmatory evidence for a genetic component in the disease
aetiology. Environmental factors, however, cannot be dis-
counted as the malignant process in any particular individual
probably has multifactorial origins.
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